Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R W Friesen

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|January 1, 1988
Spinal injuries due to front-end bale loadersR W Friesen, C E Ekong
The Biochemical Journal|January 12, 1999
[Difluro(phosphono)methyl]phenylalanine-containing peptide inhibitors of protein tyrosine phosphatasesS Desmarais, R W Friesen, R Zamboni, et al.
Analytical Biochemistry|June 13, 2001
Development of a robust scintillation proximity assay for protein tyrosine phosphatase 1B using the catalytically inactive (C215S) mutantK I Skorey, B P Kennedy, R W Friesen, et al.
Bioorganic & Medicinal Chemistry Letters|July 9, 1999
2-heterosubstituted-3-(4-methylsulfonyl)phenyl-5-trifluoromethyl pyridines as selective and orally active cyclooxygenase-2 inhibitorsD Dubé, C Brideau, D Deschênes, et al.
Bioorganic & Medicinal Chemistry Letters|May 1, 2001
In vitro metabolism considerations, including activity testing of metabolites, in the discovery and selection of the COX-2 inhibitor etoricoxib (MK-0663)N Chauret, J A Yergey, C Brideau, et al.
Bioorganic & Medicinal Chemistry Letters|January 1, 1999
Quinolines as potent 5-lipoxygenase inhibitors: synthesis and biological profile of L-746,530D Dubé, M Blouin, C Brideau, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 1999
2-Pyridinyl-3-(4-methylsulfonyl)phenylpyridines: selective and orally active cyclooxygenase-2 inhibitorsR W Friesen, C Brideau, C C Chan, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 13, 2001
Etoricoxib (MK-0663): preclinical profile and comparison with other agents that selectively inhibit cyclooxygenase-2D Riendeau, M D Percival, C Brideau, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|January 1, 1988
Spinal injuries due to front-end bale loadersR W Friesen, C E Ekong
The Biochemical Journal|January 12, 1999
[Difluro(phosphono)methyl]phenylalanine-containing peptide inhibitors of protein tyrosine phosphatasesS Desmarais, R W Friesen, R Zamboni, et al.
Analytical Biochemistry|June 13, 2001
Development of a robust scintillation proximity assay for protein tyrosine phosphatase 1B using the catalytically inactive (C215S) mutantK I Skorey, B P Kennedy, R W Friesen, et al.
Bioorganic & Medicinal Chemistry Letters|July 9, 1999
2-heterosubstituted-3-(4-methylsulfonyl)phenyl-5-trifluoromethyl pyridines as selective and orally active cyclooxygenase-2 inhibitorsD Dubé, C Brideau, D Deschênes, et al.
Bioorganic & Medicinal Chemistry Letters|May 1, 2001
In vitro metabolism considerations, including activity testing of metabolites, in the discovery and selection of the COX-2 inhibitor etoricoxib (MK-0663)N Chauret, J A Yergey, C Brideau, et al.
Bioorganic & Medicinal Chemistry Letters|January 1, 1999
Quinolines as potent 5-lipoxygenase inhibitors: synthesis and biological profile of L-746,530D Dubé, M Blouin, C Brideau, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 1999
2-Pyridinyl-3-(4-methylsulfonyl)phenylpyridines: selective and orally active cyclooxygenase-2 inhibitorsR W Friesen, C Brideau, C C Chan, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 13, 2001
Etoricoxib (MK-0663): preclinical profile and comparison with other agents that selectively inhibit cyclooxygenase-2D Riendeau, M D Percival, C Brideau, et al.
Pageof 1